Free Trial
NYSE:NGVT

Ingevity (NGVT) Stock Price, News & Analysis

$46.20
+0.36 (+0.79%)
(As of 07/26/2024 ET)
Today's Range
$45.28
$46.50
50-Day Range
$40.62
$53.54
52-Week Range
$36.66
$66.18
Volume
129,256 shs
Average Volume
187,629 shs
Market Capitalization
$1.68 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$54.17

Ingevity MarketRank™ Stock Analysis

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
17.2% Upside
$54.17 Price Target
Short Interest
Healthy
2.52% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.40mentions of Ingevity in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
31.40%
From $3.63 to $4.77 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.90 out of 5 stars

Basic Materials Sector

135th out of 175 stocks

Chemicals & Allied Products Industry

11th out of 15 stocks

NGVT stock logo

About Ingevity Stock (NYSE:NGVT)

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, paper chemicals, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts and components manufacturers through sales representatives and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

NGVT Stock Price History

NGVT Stock News Headlines

Brokerages Set Ingevity Co. (NYSE:NGVT) Target Price at $54.17
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Stifel Nicolaus Reaffirms Their Buy Rating on Ingevity (NGVT)
Jefferies Upgrades Ingevity (NGVT)
Ingevity Corporation (NGVT)
See More Headlines
Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/01/2024
Today
7/26/2024
Next Earnings (Confirmed)
7/31/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Previous Symbol
NASDAQ:NGVT
Employees
1,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$54.17
High Stock Price Target
$62.00
Low Stock Price Target
$45.00
Potential Upside/Downside
+17.2%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

Pretax Margin
-8.91%

Debt

Sales & Book Value

Annual Sales
$1.69 billion
Cash Flow
$7.57 per share
Book Value
$17.43 per share

Miscellaneous

Free Float
35,929,000
Market Cap
$1.68 billion
Optionable
Optionable
Beta
1.66
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. John C. Fortson (Age 57)
    President, CEO & Director
    Comp: $1.29M
  • Ms. Mary Dean Hall (Age 66)
    Executive VP & CFO
    Comp: $658.77k
  • Ms. Stacy Lancaster Cozad (Age 53)
    Executive VP, General Counsel & Secretary
    Comp: $615.75k
  • Mr. Stuart Edward Woodcock Jr.Mr. Stuart Edward Woodcock Jr. (Age 58)
    Executive VP & President of Performance Materials
    Comp: $823.8k
  • Mr. Richard A. White Jr. (Age 61)
    Senior VP & President of Performance Chemicals
    Comp: $575.57k
  • Mr. Phillip John Platt (Age 43)
    VP, Chief Accounting Officer & Business Transformation Lead
  • John E. Nypaver Jr.
    VP of Investor Relations & Treasurer
  • Caroline Monahan
    Director of Communications
  • Mr. Steven P. Hulme (Age 55)
    Senior VP & President of Advanced Polymer Technologies

NGVT Stock Analysis - Frequently Asked Questions

How have NGVT shares performed this year?

Ingevity's stock was trading at $47.22 at the beginning of 2024. Since then, NGVT stock has decreased by 2.2% and is now trading at $46.20.
View the best growth stocks for 2024 here
.

How were Ingevity's earnings last quarter?

Ingevity Co. (NYSE:NGVT) issued its earnings results on Wednesday, May, 1st. The company reported $0.52 earnings per share for the quarter, beating analysts' consensus estimates of $0.37 by $0.15. The company's revenue for the quarter was down 13.4% on a year-over-year basis.

What is John Fortson's approval rating as Ingevity's CEO?

2 employees have rated Ingevity Chief Executive Officer John Fortson on Glassdoor.com. John Fortson has an approval rating of 100% among the company's employees. This puts John Fortson in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are Ingevity's major shareholders?

Ingevity's top institutional investors include Bank of New York Mellon Corp (0.83%), Leeward Investments LLC MA (0.56%), Wedge Capital Management L L P NC (0.39%) and Salem Investment Counselors Inc. (0.24%). Insiders that own company stock include Stuart Edward Jr Woodcock, Erik Spencer Ripple, Richard Allen White Jr and Phillip John Platt.
View institutional ownership trends
.

How do I buy shares of Ingevity?

Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), WestRock (WRK), Abbott Laboratories (ABT) and Boeing (BA).

This page (NYSE:NGVT) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners